The best indicator for Cardinal Health (CAH)
We backtested 20 indicators across daily, weekly and hourly charts on real Cardinal Health (CAH) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Williams %R
On the weekly chart, this is the strongest risk-adjusted edge we found for Cardinal Health (CAH) over ~43.0 years — trailing buy-and-hold by 6.1% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Williams %R ✓ | Weekly | 8.4% | 0.53 | -47.0% | 74.2% | 62 | -6.1% |
| 2 | Stochastic ✓ | Weekly | 7.4% | 0.51 | -43.9% | 86.4% | 44 | -7.1% |
| 3 | EMA 20/50 Cross ✓ | Weekly | 9.4% | 0.5 | -52.5% | 50.0% | 24 | -5.2% |
| 4 | SMA 50/200 Cross ✓ | Daily | 8.8% | 0.48 | -73.1% | 39.4% | 33 | -5.8% |
| 5 | WaveTrend (8/6/4) ✓ | Daily | 8.1% | 0.48 | -51.2% | 75.9% | 166 | -6.5% |
| 6 | EMA 50/200 Cross ✓ | Daily | 8.3% | 0.46 | -72.0% | 27.8% | 36 | -6.3% |
| 7 | CCI ✓ | Weekly | 5.9% | 0.39 | -62.6% | 83.3% | 42 | -8.7% |
| 8 | MACD ✓ | Daily | 5.9% | 0.38 | -74.4% | 44.1% | 422 | -8.7% |
| 9 | Donchian Breakout ✓ | Weekly | 5.8% | 0.38 | -48.1% | 52.9% | 34 | -8.8% |
| 10 | Bollinger Mean-Reversion ✓ | Weekly | 4.8% | 0.37 | -40.9% | 90.6% | 32 | -9.7% |
| 11 | RSI Mean-Reversion ✓ | Daily | 4.1% | 0.36 | -34.3% | 68.9% | 61 | -10.5% |
| 12 | ADX / DMI ✓ | Daily | 4.9% | 0.36 | -58.9% | 43.1% | 297 | -9.7% |
| 13 | Heikin-Ashi Trend ✓ | Weekly | 5.6% | 0.36 | -76.4% | 51.5% | 398 | -8.9% |
| 14 | WaveTrend (8/6/4) ✓ | Weekly | 5.4% | 0.35 | -56.6% | 78.1% | 32 | -9.2% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Cardinal Health (CAH), Williams %R on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.